Monopoly Rights in PCD Pharma: What They Actually Mean

"Monopoly rights" means the company undertakes not to appoint another PCD partner for the same product range inside an agreed territory. It is a commercial commitment, not a legal exclusivity over the molecules themselves.

What is usually covered

• The specific brand names in your allotted list
• A named district, group of districts, or state
• The duration stated in the agreement, often renewed annually

What is usually not covered

• The generic molecules — other companies sell the same compositions freely
• Institutional, tender or hospital supply, which is frequently carved out
• Brands outside your allotted list, even in your own territory
• Online or cross-territory sales made by third parties you do not control

Clauses to read carefully

Look for the minimum purchase commitment, since most agreements make the monopoly conditional on it. Check the notice period for termination, whether the territory is defined by district or by pin code, and what happens to your stock and outstanding claims if the arrangement ends.

A practical test

Ask the company to put the territory and the brand list in the annexure of the agreement, not just in an email. Anything that is genuinely exclusive can be written down.